EGF and cancer: To make a few examples, metastatic cancer cells abnormally enhance the autocrine signaling of growth factors, namely fibroblast growth factor (FGF) and epidermal growth factor (EGF), to activate the pro-survival PI3K/Akt, Ras/MAPK, NF-κB, and Rho-GTPase signaling pathways [9].